Skip to content

Our Company
Technology
Proteins & Adjuvants
Newsroom
Contact
Cookie Policy
Privacy Policy
Terms of Use

Hawaii Biotech Awarded $38.5 Million for Continued Development of Anti‐toxin Drug to Treat Anthrax in Humans

Post navigation

Previous: Hawaii Biotech to Develop Ebola Vaccine With the University of Hawai’i

Next: Hawaii Biotech and Uh School of Medicine on Track for Zika Vaccine

Search for:

Recent Posts

Hello world!

Recent Comments

A WordPress Commenter on Hello world!

Archives

March 2021

Categories

Uncategorized

Meta

Log in
Entries feed
Comments feed
WordPress.org

Our Company
Technology
Proteins & Adjuvants
Newsroom
Contact
Cookie Policy
Privacy Policy
Terms of Use

Cookie Policy | Privacy Policy | Terms of Use

Copyright © 2024 Hawaii Biotech Inc. All rights reserved.